Fasiglifam(TAK875)

CAS1000413-72-8

Fasiglifam(TAK875) (CAS 1000413-72-8, C29H32O7S) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of Fasiglifam(TAK875)
C29H32O7S · 524.62 g/mol
CAS No.
1000413-72-8
Formula
C29H32O7S
Mol. weight
524.62 g/mol

Chemical Specifications

Identifiers

CAS number 1000413-72-8
Product name Fasiglifam(TAK875)
Chinese name (3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸
Synonyms TAK875; 3-Benzofuranacetic acid, 6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-, (3S)-
Molecular formula C29H32O7S
Molecular weight 524.62 g/mol

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of Fasiglifam(TAK875)?

The CAS Registry Number of Fasiglifam(TAK875) is 1000413-72-8. Fasiglifam(TAK875) is also known as TAK875; 3-Benzofuranacetic acid, 6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-, (3S)-.

What is the molecular formula and molecular weight of Fasiglifam(TAK875)?

The molecular formula of Fasiglifam(TAK875) is C29H32O7S, and its molecular weight is 524.62 g/mol.

How can I request a quotation for Fasiglifam(TAK875)?

Send an inquiry for Fasiglifam(TAK875) (CAS 1000413-72-8) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for Fasiglifam(TAK875)

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.